South Korea’s leading clinical diagnostics company, Green Cross Laboratories (GC Labs) is expanding its operations in the Middle East with new partnership agreements with Abu Dhabi-based Life Diagnostics (Life Dx) and Jordan’s Precision Medical Laboratory (PML).
The agreements were signed at the ongoing Medlab Middle East 2022 event, where GC Labs is exhibiting its ‘smart experience’ for visitors to learn more about the diagnostic services offered by the company.
Established in 1998, Life Dx is a fully-fledged diagnostic center that offers a wide range of laboratory and radiology services through adopting innovative technologies. Life Dx was already a partner for GC Labs in the UAE, and now with the new agreement, the center will also collaborate with the South Korean company in Oman, Saudi Arabia and Egypt.
Speaking about the new partnership agreement, Mr. Hosam Fouad, Founder and CEO at Life Dx, said, “We are excited to announce our regional partnership with Korea’s leading clinical laboratory, GC Labs. The new partnership will help Life Dx to offer premium quality testing and lab services to our clients, including esoteric and high complexity testing at competitive rates.”
“There is strong regional demand for our laboratory testing services and, now with new and expanded agreements with our partners, we will be able to provide our services to more countries in the Middle East. Growing awareness of infectious diseases combined with government investments in healthcare, continue to drive demand for laboratory testing services in the region.”
Commenting on the partnership, Dr. Bashar, Executive Director at PML, remarked, “It is with great anticipation that we sign a business collaboration with GC Labs, globally known as a leading clinical diagnostics laboratory. This collaboration will strengthen our clinical diagnostics services, and we hope to grow together with GC Labs, not only in Jordan, but also in the greater Middle East region.”
During the Medlab Middle East 2022, GC Labs also hosted a live discussion on “Public-Private Partnership in Global Health: bringing the best of both worlds to improve testing.”